114 related articles for article (PubMed ID: 6151589)
1. Tyrosine hydroxylase protein in Lewy bodies of parkinsonian and senile brains.
Nakashima S; Ikuta F
J Neurol Sci; 1984 Oct; 66(1):91-6. PubMed ID: 6151589
[TBL] [Abstract][Full Text] [Related]
2. Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies.
Dugger BN; Dickson DW
Acta Neuropathol; 2010 Nov; 120(5):633-9. PubMed ID: 20721565
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system.
Wakabayashi K; Takahashi H; Ohama E; Ikuta F
Acta Neuropathol; 1990; 79(6):581-3. PubMed ID: 1972853
[TBL] [Abstract][Full Text] [Related]
4. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
5. [Topography of the catecholamine neurons in the brain stem of the human fetus: an immunohistochemical study using antibodies to tyrosine hydroxylase].
Takahashi H; Nakashima S; Ohama E; Takeda S; Ikuta F
No To Shinkei; 1986 Jan; 38(1):87-97. PubMed ID: 2870726
[TBL] [Abstract][Full Text] [Related]
6. Homospecific activity (activity per enzyme protein) of tyrosine hydroxylase increases in parkinsonian brain.
Mogi M; Harada M; Kiuchi K; Kojima K; Kondo T; Narabayashi H; Rausch D; Riederer P; Jellinger K; Nagatsu T
J Neural Transm; 1988; 72(1):77-82. PubMed ID: 2897999
[TBL] [Abstract][Full Text] [Related]
7. CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathies.
Riederer P; Rausch WD; Birkmayer W; Jellinger K; Seemann D
J Neural Transm Suppl; 1978; (14):121-31. PubMed ID: 39974
[TBL] [Abstract][Full Text] [Related]
8. Catecholamine neurons with Alzheimer's neurofibrillary changes and alteration of tyrosine hydroxylase. Immunohistochemical investigation of tyrosine hydroxylase.
Nakashima S; Ikuta F
Acta Neuropathol; 1985; 66(1):37-41. PubMed ID: 2859729
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3beta is associated with Parkinson's disease.
Nagao M; Hayashi H
Neurosci Lett; 2009 Jan; 449(2):103-7. PubMed ID: 19007860
[TBL] [Abstract][Full Text] [Related]
10. Distribution of catecholamine-synthesizing enzymes in goldfish brains: presumptive dopamine and norepinephrine neuronal organization.
Hornby PJ; Piekut DT
Brain Behav Evol; 1990; 35(1):49-64. PubMed ID: 1971189
[TBL] [Abstract][Full Text] [Related]
11. Decrease of medullary catecholaminergic neurons in multiple system atrophy and Parkinson's disease and their preservation in amyotrophic lateral sclerosis.
Kato S; Oda M; Hayashi H; Shimizu T; Hayashi M; Kawata A; Tanabe H
J Neurol Sci; 1995 Oct; 132(2):216-21. PubMed ID: 8543951
[TBL] [Abstract][Full Text] [Related]
12. [Tyrosine hydroxylase in the catecholamine neurons of the autopsy brains with degenerative neurological disorder].
Nakashima S; Ikuta F
Rinsho Shinkeigaku; 1984 Jul; 24(7):716-22. PubMed ID: 6149832
[No Abstract] [Full Text] [Related]
13. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
[TBL] [Abstract][Full Text] [Related]
14. [Parkinson's disease: the distribution of Lewy bodies in the peripheral autonomic nervous system].
Wakabayashi K
No To Shinkei; 1989 Oct; 41(10):965-71. PubMed ID: 2557873
[TBL] [Abstract][Full Text] [Related]
15. Aromatic L-amino acid decarboxylase-immunoreactive structures in human midbrain, pons, and medulla.
Kitahama K; Ikemoto K; Jouvet A; Araneda S; Nagatsu I; Raynaud B; Nishimura A; Nishi K; Niwa S
J Chem Neuroanat; 2009 Oct; 38(2):130-40. PubMed ID: 19589383
[TBL] [Abstract][Full Text] [Related]
16. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of abnormalities of sympathetic tyrosine hydroxylase and alpha-synuclein in chronic autonomic failure.
Isonaka R; Sullivan P; Jinsmaa Y; Corrales A; Goldstein DS
Clin Auton Res; 2018 Apr; 28(2):223-230. PubMed ID: 29396794
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of tyrosine hydroxylase and anomalous neurites in catecholaminergic neurons of ATF-2 null mice.
Kojima M; Suzuki T; Maekawa T; Ishii S; Sumi-Ichinose C; Nomura T; Ichinose H
J Neurosci Res; 2008 Feb; 86(3):544-52. PubMed ID: 17896792
[TBL] [Abstract][Full Text] [Related]
19. Ca2+/calmodulin-dependent protein kinase II immunoreactivity in Lewy bodies.
Iwatsubo T; Nakano I; Fukunaga K; Miyamoto E
Acta Neuropathol; 1991; 82(3):159-63. PubMed ID: 1656693
[TBL] [Abstract][Full Text] [Related]
20. Clinical and neuropathological correlates of Lewy body disease.
Hishikawa N; Hashizume Y; Yoshida M; Sobue G
Acta Neuropathol; 2003 Apr; 105(4):341-50. PubMed ID: 12624787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
